What a difficult experience involves

The largest survey on this asked 1,993 people to describe the single most challenging experience they had ever had on psilocybin mushrooms. What it found, in plain numbers: 39% ranked that experience among the five most difficult of their entire life. 11% said they had put themselves or someone else at risk of physical harm, and 2.6% described behaving aggressively or violently. 2.7% sought medical help. Among those whose experience had happened more than a year earlier, 7.6% had sought treatment for psychological symptoms that persisted afterward.

Those numbers need their denominator stated, or they mislead in both directions. Everyone in that survey was asked about their worst experience, and they found the survey and chose to answer it. So these figures describe what a hard experience can involve when it happens. They are not the odds that any given experience goes this way, and no study design here can give you that number.

Held against those same figures: 84% of the same respondents said they still benefited from the experience. That is not a reassurance placed on top of the harm, and it does not cancel it. It means both things are routinely true of the same event, sometimes for the same person — that a difficult experience can do real damage that needs real help, and can still be something the person judges as worth having had.

What that research names, plainly: fear out of proportion to any present danger, a feeling of losing control, grief, isolation, physical distress, paranoia, insight that overwhelmed rather than clarified, and a sense that your own self had changed or gone missing. These recur consistently enough that researchers built a dedicated instrument to characterize them — which is the useful thing to know. A hard experience is a documented, studied, common phenomenon, not a sign that something unusual happened to you or that you handled it wrong.

If something about your situation raises the odds of a hard experience, Consider pausing or reconsidering covers what is worth weighing.

Even in clinical settings, with screening and supervision in place, a systematic review of serotonergic psychedelics and MDMA found that adverse events do occur, at rates varying by substance and study. “Clinical” and “controlled” reduce risk. They do not eliminate it.